急性重症胰腺炎属于常见急腹症的一种,主要引发原因是胰腺中的胰液被激活,不仅可使胰腺组织有出血、水肿、坏死等出现,而且可使全身出现炎性反应,进而导致机体其他器官出现障碍,死亡率可达25%[1]。此病治疗中,奥曲肽经常被应用,可对胰腺液的分泌进行抑制,使胰腺管内的压力降低,但对于全身炎性反应,此药控制效果不够理想。本文采用奥曲肽联合乌司他丁治疗急性重症胰腺炎患者,现将临床治疗效果报告如下。 Acute severe pancreatitis is a kind of common acute abdomen, the main cause is that pancreatic juice is activated, not only pancreatic tissue bleeding, edema, necrosis and so on, but also make the whole body an inflammatory reaction, which led to the body Obstacles to other organs, the mortality rate of up to 25% [1]. In the treatment of this disease, octreotide is often used to inhibit the secretion of pancreatic juice, reducing the pressure in the pancreatic duct, but systemic inflammatory response, the drug control effect is not ideal. In this paper, octreotide combined with ulinastatin in patients with severe acute pancreatitis, the clinical treatment is now reported as follows.